Compounds > ebselen

ebselen and shikonin

ebselen has been researched along with shikonin in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	4 (100.00)	2.80

Authors

Authors	Studies
Alonso, C; Barrado-Gil, L; Campillo, NE; Cuesta-Geijo, MÁ; Gil, C; Ginex, T; Maestro, I; Martinez, A; Nozal, V; Ramírez, D; Urquiza, J	1
Amin, SA; Banerjee, S; Gayen, S; Ghosh, K; Jha, T	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Servidio, C; Stellacci, F	1

Reviews

3 review(s) available for ebselen and shikonin

Article	Year
COVID-19: Drug Targets and Potential Treatments. Journal of medicinal chemistry, 2020, 11-12, Volume: 63, Issue:21 Topics: Amino Acid Sequence; Animals; Antiviral Agents; COVID-19 Drug Treatment; Drug Repositioning; Enzyme Inhibitors; Humans; Immunity, Innate; SARS-CoV-2	2020
Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors. Bioorganic & medicinal chemistry, 2021, 01-01, Volume: 29 Topics: Antiviral Agents; Catalytic Domain; Coronavirus 3C Proteases; Cysteine Proteinase Inhibitors; Drug Discovery; Drug Evaluation, Preclinical; Molecular Docking Simulation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; SARS-CoV-2	2021
Therapeutic approaches against coronaviruses acute respiratory syndrome. Pharmacology research & perspectives, 2021, Volume: 9, Issue:1 Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Azoles; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Humans; Isoindoles; Naphthoquinones; Organoselenium Compounds; Severe Acute Respiratory Syndrome	2021

Other Studies

1 other study(ies) available for ebselen and shikonin

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023